Gerald Commissiong

Chief Business Officer
Gerald is a healthcare executive who's spent 15+ years in the C-Suite, leading growth in therapeutics, diagnostics, and natural products. To date, he has raised over $70M in capital and holds a BS from Stanford.
See full team
Gerald Commisiong
Background

Mr. Gerald Commissiong is healthcare executive with over 15 years of experience serving in C-suite roles in emerging growth companies developing and commercializing novel therapeutics, diagnostics and natural products to address acute and chronic diseases. He previously served as President & CEO of Amarantus Bioscience Holdings, Inc. and Todos Medical, Ltd. helping raise over $70 million in equity and debt capital. His experience spans neurology, regenerative medicine, oncology and infectious disease. Mr. Commissiong received a BS in Management Science & Engineering with a focus on financial decisions from Stanford University and played professional football in the Canadian Football League for the Calgary Stampeders.

Our Pipeline

The Future of Cancer Treatment

OS Therapies is not just addressing Osteosarcoma. With the other uses of our HER2 target cancer immunotherapy and the addition of our OST-tADC tunable Antibody Drug Conjugate silicone linker platform, we are paving the way for the next-generation of cancer treatments.
Female chemist working on osteosarcoma treatments | OS TherapiesLab technician working on cancer treatments | OS TherapiesFemale chemist working on cancer treatments